398 related articles for article (PubMed ID: 32276274)
41. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
[TBL] [Abstract][Full Text] [Related]
42. Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort.
Di Benedetto P; Cipriani P; Iacono D; Pantano I; Caso F; Emmi G; Grembiale RD; Cantatore FP; Atzeni F; Perosa F; Scarpa R; Guggino G; Ciccia F; Giacomelli R; Ruscitti P
PLoS One; 2020; 15(7):e0235326. PubMed ID: 32645077
[TBL] [Abstract][Full Text] [Related]
43. Increased neutrophil extracellular traps activate NLRP3 and inflammatory macrophages in adult-onset Still's disease.
Hu Q; Shi H; Zeng T; Liu H; Su Y; Cheng X; Ye J; Yin Y; Liu M; Zheng H; Wu X; Chi H; Zhou Z; Jia J; Sun Y; Teng J; Yang C
Arthritis Res Ther; 2019 Jan; 21(1):9. PubMed ID: 30616678
[TBL] [Abstract][Full Text] [Related]
44. Anakinra in patients with treatment-resistant adult-onset Still's disease: four case reports with serial cytokine measurements and a review of the literature.
Kötter I; Wacker A; Koch S; Henes J; Richter C; Engel A; Günaydin I; Kanz L
Semin Arthritis Rheum; 2007 Dec; 37(3):189-97. PubMed ID: 17583775
[TBL] [Abstract][Full Text] [Related]
45. sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia.
Colafrancesco S; Priori R; Alessandri C; Astorri E; Perricone C; Blank M; Agmon-Levin N; Shoenfeld Y; Valesini G
Immunol Res; 2014 Dec; 60(2-3):177-83. PubMed ID: 25388964
[TBL] [Abstract][Full Text] [Related]
46. The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still's disease: A STROBE-compliant retrospective observational analysis.
Seo JY; Suh CH; Jung JY; Kim AR; Yang JW; Kim HA
Medicine (Baltimore); 2017 Jul; 96(29):e7546. PubMed ID: 28723775
[TBL] [Abstract][Full Text] [Related]
47. Percentage of glycosylated serum ferritin remains low throughout the course of adult onset Still's disease.
Vignes S; Le Moël G; Fautrel B; Wechsler B; Godeau P; Piette JC
Ann Rheum Dis; 2000 May; 59(5):347-50. PubMed ID: 10784516
[TBL] [Abstract][Full Text] [Related]
48. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis.
Tian R; Chen X; Yang C; Teng J; Qu H; Liu HL
Front Immunol; 2021; 12():654811. PubMed ID: 33868298
[TBL] [Abstract][Full Text] [Related]
49. Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis.
Inoue N; Shimizu M; Tsunoda S; Kawano M; Matsumura M; Yachie A
Clin Immunol; 2016 Aug; 169():8-13. PubMed ID: 27263804
[TBL] [Abstract][Full Text] [Related]
50. A comprehensive review on adult onset Still's disease.
Giacomelli R; Ruscitti P; Shoenfeld Y
J Autoimmun; 2018 Sep; 93():24-36. PubMed ID: 30077425
[TBL] [Abstract][Full Text] [Related]
51. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
[TBL] [Abstract][Full Text] [Related]
52. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease.
Jung SY; Park YB; Ha YJ; Lee KH; Lee SK
J Rheumatol; 2010 May; 37(5):1029-34. PubMed ID: 20231196
[TBL] [Abstract][Full Text] [Related]
53. Extremely High Serum Ferritin: An Instrumental Marker of Masquerading Adult-Onset Still's Disease with Hemophagocytic Syndrome.
Yamashita S; Furukawa NE; Matsunaga T; Hirakawa Y; Tago M; Yamashita SI
Am J Case Rep; 2017 Dec; 18():1296-1301. PubMed ID: 29208852
[TBL] [Abstract][Full Text] [Related]
54. Potential role of adenosine deaminase in the diagnosis of adult-onset Still's disease.
Xun C; Zhao Y; Hu ZJ
Rheumatol Int; 2013 May; 33(5):1255-8. PubMed ID: 23096558
[TBL] [Abstract][Full Text] [Related]
55. Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still's disease.
Yoshida Y; Sakamoto M; Yokota K; Sato K; Mimura T
Intern Med; 2011; 50(16):1757-60. PubMed ID: 21841340
[TBL] [Abstract][Full Text] [Related]
56. Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease.
Chen DY; Lin CC; Chen YM; Lan JL; Hung WT; Chen HH; Lai KL; Hsieh CW
Arthritis Res Ther; 2013 Mar; 15(2):R39. PubMed ID: 23497717
[TBL] [Abstract][Full Text] [Related]
57. Differences and similarities in cytokine profiles of macrophage activation syndrome in systemic lupus erythematosus and adult-onset Still's disease.
Hiyama T; Kurasawa K; Hasegawa A; Miyao T; Tanaka A; Arai S; Arima M; Maezawa R
Clin Exp Med; 2023 Nov; 23(7):3407-3416. PubMed ID: 36611087
[TBL] [Abstract][Full Text] [Related]
58. New Markers for Adult-Onset Still's Disease.
Mitrovic S; Fautrel B
Joint Bone Spine; 2018 May; 85(3):285-293. PubMed ID: 28529117
[TBL] [Abstract][Full Text] [Related]
59. Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease.
Ruscitti P; Ursini F; Berardicurti O; Masedu F; Bozzalla Cassione E; Naldi S; Di Cola I; Di Muzio C; De Stefano L; Di Nino E; Navarini L; Vomero M; Bugatti S; Valenti M; Mariani E; Iagnocco A; Montecucco C; Giacomelli R; Cipriani P
Rheumatology (Oxford); 2022 Dec; 62(1):321-329. PubMed ID: 35438139
[TBL] [Abstract][Full Text] [Related]
60. The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still's disease.
Lee SW; Park YB; Song JS; Lee SK
J Rheumatol; 2009 Jan; 36(1):156-62. PubMed ID: 19040301
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
